Acumen Pharmaceuticals
ABOS
#9394
Rank
โ‚น5.15 B
Marketcap
โ‚น85.11
Share price
-5.99%
Change (1 day)
-73.73%
Change (1 year)

Revenue for Acumen Pharmaceuticals (ABOS)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acumen Pharmaceuticals from 2020 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น27.57 M